PET-CT

PET-CT is an imaging test that combines a positron emission tomography (PET) scan with a computed tomography (CT) scan in a single session. The PET portion uses a small amount of radioactive sugar to highlight cells that are using energy at a high rate, such as cancer cells, while the CT portion provides detailed anatomic pictures. Together they show both where abnormal activity is happening and exactly what part of the body it is in.

Origin

PET imaging was developed in the 1970s, and the first combined PET-CT scanner was introduced in 1998 by physicists David Townsend and Ronald Nutt. The combined technology became widely available in cancer centers in the early 2000s and is now standard for staging many cancers, including mesothelioma.

Significance in Asbestos Context

For someone with suspected or confirmed mesothelioma or asbestos-related cancer, PET-CT is one of the key tools used to stage the disease, meaning to determine how far it has spread. It can help distinguish active tumor from benign pleural thickening or old scar tissue, identify lymph node involvement, and detect distant spread that a CT alone might miss. The findings often guide whether surgery, chemotherapy, immunotherapy, or radiation is appropriate, and they frequently appear in medical records and expert reports used to document the extent of disease in a legal claim.

Example Sentence

After her pleural biopsy confirmed mesothelioma, her oncologist ordered a PET-CT to see whether the cancer had spread beyond the chest wall before discussing treatment options.

Related Terms

CT Scan, Staging, Mesothelioma, Pleural Thickening, SUV (Standardized Uptake Value), FDG

Notes

• Ask your oncologist whether a PET-CT is being used for initial staging, to assess treatment response, or to look for recurrence. The purpose affects how results should be interpreted.
• Request copies of both the PET-CT images (on disc) and the written radiology report; these are important medical records for treatment planning and may be needed for legal documentation.
• Benign pleural plaques and post-surgical inflammation can sometimes show uptake on PET-CT, so ask whether any 'hot spots' have been correlated with biopsy or prior imaging before conclusions are drawn.
• Tell the scheduling team if you are diabetic, pregnant, or claustrophobic; blood sugar must usually be controlled before FDG injection, and you will need to fast for several hours beforehand.